Melatonin as an apoptosis antagonist

Annals of the New York Academy of Sciences

Volumn 1090, Issue , 2006, Pages 226-233

  Radogna, Flavia ^a,d   Paternoster, Laura ^a   Albertini, Maria Cristina ^c   Accorsi, Augusto ^c   Cerella, Claudia ^a   D'Alessio, Maria ^a   De Nicola, Milena ^a   Nuccitelli, Silvia ^a   Magrini, Andrea ^b   Bergamaschi, Antonio ^b   Ghibelli, Lina ^a  

^a Dipartimento di Biologia   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; Melatonin; Receptor engagement

Indexed keywords

MELATONIN; MELATONIN 1 RECEPTOR; PLASMA PROTEIN;

APOPTOSIS; CELL DAMAGE; CELL STRAIN U937; CONFERENCE PAPER; FETAL CALF SERUM; HUMAN; HUMAN CELL; RECEPTOR AFFINITY; STIMULATION; ARTICLE; CULTURE MEDIUM; DRUG EFFECT; METABOLISM;

APOPTOSIS; BLOOD PROTEINS; CULTURE MEDIA; HUMANS; MELATONIN; U937 CELLS;

EID: 34247555972     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.025     Document Type: Conference Paper

References (15)

1. REITER, R.J. 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12: 151-180.
2. CARRILLO-VICO, A., J.R. CALVO, P. ABREU, et al. 2004. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possibile role as intracrine, autocrine, and/or paracrine substance. FASEB J. 18: 537-539.
3. GILAD, E. & N. ZISAPEL. 1995. High-affinity binding of melatonin to hemoglobin. Biochem. Mol. Med. 56: 115-120.
4. SAINZ, R.M., J.C. MAYO, C. RODRIGUEZ, et al. 2003. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol. Life Sci. 60: 1407-1426.
5. VANEK, J. 1998. Cellular mechanism of melatonin action. Physiol. Rev. 78: 687-721.
6. REITER, R.J., J.R. CALVO, M. KARBOWNIK, et al. 2000. Melatonin and its relation to the immune system and inflammation. Ann. N. Y. Acad. Sci. 917: 376-386.
7. REITER, R.J., D.X. TAN, C. OSUNA, et al. 2000. Action of melatonin in the reduction of oxidative stress. J. Biomed. Sci. 7: 444-458.
8. DUBOCOVICH, M.L. & M. MARKOWSKA. 2005. Functional MT1and MT2 melatonin receptor in mammals. Endocrine 27: 101-110.
9. DUBOCOVICH, M.L. 1991. Pharmacological characterization of melatonin binding sites. Adv. Pineal Res. 5: 167-173.
10. WOLFLER, A., H.C. CALUBA, P.M. ABUJA, et al. 2001. Pro-oxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett. 502: 127-131.
11. SAINZ, R.M., J.C. MAYO, R.J. REITER, et al. 1999. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J. 13: 1547-1556.
12. GARCIA-MAURINO, S., M.G. GONZALEZ-H ABA, J.R. CALVO, et al. 1998. Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells. J. Immunol. 92: 76-84.
13. JUKNAT, A.A., M. DEL VALLE, A. MENDEZ, et al. 2005. Melatonin prevents hydrogen peroxide-induced Bax expression in cultured rat astrocytes. J. Pineal Res. 38: 84-92.
14. ECK, K.M., L. YUAN, L. DUFFY, et al. 1998. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br. J. Cancer 77: 2129-2137.
15. POST, A., F. HOLSBOER & C. BEHL. 1998. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. J. Neurosci. 18: 8236-8246.